Clinical Trial Update: Paclitaxel With Trastuzumab and Lapatinib in HER2-Positive Early Stage Breast Cancer [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating paclitaxel in combination with trastuzumab and lapatinib in HER2-positive early-stage breast cancer has completed with resul…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Lapatinib (Lapatinib)
• PACLITAXEL (PACLITAXEL)
• Trastuzumab (trastuzumab)

Snippet

Sponsor: Memorial Sloan Kettering Cancer Center | Conditions: HER2-Positive Early Stage Breast Cancer | Phase 2 | Status: COMPLETED | Results posted: 2019-12-18